TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
+47.93%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$1.08B
AUM Growth
+$1.08B
(+53%)
Cap. Flow
+$243M
Cap. Flow
% of AUM
22.47%
Top 10 Holdings %
Top 10 Hldgs %
41.77%
Holding
136
New
30
Increased
24
Reduced
21
Closed
13
Top Buys
Top Sells
| 1 |
EQRX
EQRx, Inc. Common Stock
EQRX
|
$22.4M |
| 2 |
THRD
Third Harmonic Bio
THRD
|
$11.5M |
| 3 |
NovoCure
NVCR
|
$7.95M |
| 4 |
Intellia Therapeutics
NTLA
|
$6.02M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
$5.99M |
Sector Composition
| 1 | Healthcare | 95.77% |
| 2 | Financials | 3.5% |
| 3 | Real Estate | 0.65% |
| 4 | Technology | 0.08% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KRTX
76
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $3.17M | 0.29% | 10,000 | – | – |
|
77
Heron Therapeutics
HRTX
$207M
| $3.15M | 0.29% | 1,850,000 | – | – |
|
78
InflaRx
IFRX
$108M
| $3.05M | 0.28% | 1,873,753 -950,600 | -34% | -$1.55M |
|
79
Amylyx Pharmaceuticals
AMLX
$836M
| $2.94M | 0.27% | +200,000 | New | +$2.94M |
|
80
Enanta Pharmaceuticals
ENTA
$180M
| $2.82M | 0.26% | +300,000 | New | +$2.82M |
|
81
Athira Pharma
ATHA
$15.3M
| $2.8M | 0.26% | 1,152,715 +800,000 | +227% | +$1.94M |
|
|
AMRN
82
Amarin Corp
AMRN
$311M
| $2.69M | 0.25% | 3,086,544 -2,775,973 | -47% | -$2.42M |
|
83
Fate Therapeutics
FATE
$120M
| $2.62M | 0.24% | 700,000 | – | – |
|
84
Seres Therapeutics
MCRB
$166M
| $2.51M | 0.23% | +1,792,888 | New | +$2.51M |
|
85
Passage Bio
PASG
$22.7M
| $2.42M | 0.22% | 2,400,000 +2,000,000 | +500% | +$2.02M |
|
|
ENZ
86
DELISTED
Enzo Biochem, Inc.
ENZ
| $2.36M | 0.22% | 1,700,000 -500,000 | -23% | -$695K |
|
|
BLUE
87
DELISTED
bluebird bio
BLUE
| $2.35M | 0.22% | 1,700,000 -2,582,827 | -60% | -$3.56M |
|
88
ARS Pharmaceuticals
SPRY
$1.15B
| $2.24M | 0.21% | 409,463 | – | – |
|
89
Editas Medicine
EDIT
$231M
| $2.03M | 0.19% | 200,000 | – | – |
|
90
ServisFirst Bancshares
SFBS
$4.81B
| $2M | 0.18% | 30,000 | – | – |
|
91
PDS Biotechnology
PDSB
$57.8M
| $1.99M | 0.18% | 400,000 | – | – |
|
92
Tango Therapeutics
TNGX
$747M
| $1.98M | 0.18% | 200,000 | – | – |
|
|
ELEV
93
DELISTED
Elevation Oncology
ELEV
| $1.97M | 0.18% | 3,667,600 -332,400 | -8% | -$178K |
|
94
MEI Pharma
MEIP
$160M
| $1.89M | 0.17% | 326,084 | – | – |
|
|
GNFT
95
Genfit
GNFT
$200M
| $1.85M | 0.17% | 479,441 -561,195 | -54% | -$2.16M |
|
96
Aclaris Therapeutics
ACRS
$209M
| $1.84M | 0.17% | +1,753,335 | New | +$1.84M |
|
97
TG Therapeutics
TGTX
$4.65B
| $1.71M | 0.16% | 100,000 | – | – |
|
98
Adicet Bio
ACET
$59.9M
| $1.66M | 0.15% | 876,352 -350,000 | -29% | -$662K |
|
99
Aligos Therapeutics
ALGS
$73.3M
| $1.45M | 0.13% | 2,189,847 -1,139,201 | -34% | -$756K |
|
100
LAVA Therapeutics
LVTX
$41.3M
| $1.33M | 0.12% | +840,593 | New | +$1.33M |
|